Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Melatonin Receptor 1B Antikörper (AA 232-246)

Der Kaninchen Polyklonal Anti-Melatonin Receptor 1B-Antikörper wurde für WB, IHC, IF und IC validiert. Er ist geeignet, Melatonin Receptor 1B in Proben von Maus zu detektieren.
Produktnummer ABIN7043327

Kurzübersicht für Melatonin Receptor 1B Antikörper (AA 232-246) (ABIN7043327)

Target

Alle Melatonin Receptor 1B (MTNR1B) Antikörper anzeigen
Melatonin Receptor 1B (MTNR1B)

Reaktivität

  • 31
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
Maus

Wirt

  • 32
  • 1
  • 1
Kaninchen

Klonalität

  • 33
  • 1
Polyklonal

Konjugat

  • 22
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Melatonin Receptor 1B Antikörper ist unkonjugiert

Applikation

  • 16
  • 16
  • 10
  • 6
  • 5
  • 4
  • 3
  • 3
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunochromatography (IC)
  • Bindungsspezifität

    • 5
    • 5
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 232-246

    Verwendungszweck

    A Rabbit Polyclonal Antibody to Melatonin Receptor Type 1B

    Spezifität

    3rd intracellular loop

    Kreuzreaktivität

    Maus, Ratte

    Kreuzreaktivität (Details)

    Unlikely to recognize human samples.

    Homologie

    Rat - 14,15 amino acid residues identical

    Produktmerkmale

    Anti-Melatonin Receptor 1B (MTNR1B) Antibody (ABIN7043327, ABIN7044601 and ABIN7044602) is a highly specific antibody directed against an epitope of mouse MT2. The antibody can be used in western blot and immunohistochemistry applications. It has been designed to recognize MT2 from rat and mouse samples. The antibody is unlikely to recognize the receptor in human samples.

    Aufreinigung

    Affinity purified on immobilized antigen.

    Immunogen

    Immunogen: Synthetic peptide

    Immunogen Sequence: (C)RKAKATRKLRLRPSD, corresponding to amino acid residues 232-246 of mouse MTNR1B

    Isotyp

    IgG
  • Applikationshinweise

    Antigen preadsorption control: 1 μg peptide per 1 μg antibody

    Application Dilutions Immunohistochemistry paraffin embedded sections ihc: 1:600-1:2000

    Application Dilutions Western blot wb: 1:200

    Kommentare

    Cited Application: IHC|ICC

    Negative Control: (ABIN7235940)

    Blocking Peptide: (ABIN7235940)

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    0.2 mL double distilled water (DDW).

    Konzentration

    1 mg/mL

    Buffer

    PBS pH 7.4

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

    Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

  • Target

    Melatonin Receptor 1B (MTNR1B)

    Andere Bezeichnung

    MTNR1B

    Hintergrund

    Melatonin receptor type 2, MT2, Mel1b receptor, Mel-1B-R,Melatonin (N-acetyl-5-methoxytryptamine) is a product of tryptophan metabolism. It is synthesized in the pineal gland and is secreted to control the circadian rhythm1-3. Melatonin is also synthesized in the gastrointestinal tract, retina, skin and other tissues where it acts in a autocrine or paracrine manner. The role of melatonin in these tissues is independent of its role in the circadian rhythm, where it plays a role in energy metabolism, physiological growth, differentiation and responsiveness in stress stimuli1. The pleiotropic effects of melatonin have given rise to various therapeutic possibilities for this molecule. For example, anti-stress, sexual dysfunction, obesity, gallbladder stones1,4. To date, the only therapeutic uses for melatonin remain to treat sleep disorders, depression, migraine and headaches1.Melatonin exerts its effects through two G-protein coupled receptors (GPCRs), melatonin receptor type 1 and melatonin receptor type 2 (MT1 and MT2). Like all GPCRs, they have seven transmembrane domains and extracellular N-terminal and cytoplasmic C-terminal tails. The binding of melatonin to either receptor activates Gi, thereby activating PLC, thus increasing intracellular Ca2+ levels. Both receptors structurally bind melatonin in the same manner, although MT2 displays a much higher affinity for the hormone. Just like melatonin levels are detected in many tissues, the expression patterns of the two receptors are also quite broad. For example, MT1 is detected in the brain, retina and kidneys and MT2 is expressed in brain and in the retina1.MT1 is involved in sleep regulation and might also have effects on peripheral vasoconstriction. MT2 may play an important physiological role in the retina and might regulate body temperature1.

    Alternative names: Melatonin Receptor 1B (MTNR1B), Melatonin receptor type 2, MT2, Mel1b receptor, Mel-1B-R

    Gen-ID

    244701

    NCBI Accession

    NM_005959

    UniProt

    Q8CIQ6
Sie sind hier:
Chat with us!